Theravance Biopharma, Inc.
DE ˙ DB ˙ KYG8807B1068
13,90 € ↑0,30 (2,21%)
2026-06-05
DEL PRIS
SecurityDE:0TB / Theravance Biopharma, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership86,091 shares
Latest Disclosed Value $ 1,397,257
Citadel Advisors Llc ownership in 0TB / Theravance Biopharma, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 86,091 shares of Theravance Biopharma, Inc. (DE:0TB) valued at $1,136,401 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 235,700 shares of Theravance Biopharma, Inc.. This represents a change in shares of -63.47% during the quarter. The current value of the position is $1,196,665 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (0TB) in the form of stock options. The firm currently holds call options representing 19,900 of underlying shares valued at $322,977 USD and put options representing 12,200 of underlying shares valued at $198,006 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:0TB / Theravance Biopharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 86,091 -149,609 -63.47 1,397 -68.31 0.0002
2026-02-17 2025-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 235,700 184,833 363.37 4,410 494.20 0.0007
2025-11-14 2025-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 50,867 -434,464 -89.52 743 -86.14 0.0001
2025-08-14 2025-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 485,331 46,622 10.63 5,353 36.66 0.0009
2025-05-15 2025-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 438,709 124,087 39.44 3,918 32.33 0.0007
2025-02-14 2024-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 314,622 80,066 34.14 2,961 56.61 0.0005
2024-11-14 2024-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 234,556 -9,458 -3.88 1,891 -8.65 0.0004
2024-08-14 2024-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 244,014 128,206 110.71 2,069 99.33 0.0004
2024-05-15 2024-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 115,808 -34,314 -22.86 1,039 -38.47 0.0002
2024-02-14 2023-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 150,122 113,403 308.84 1,687 433.86 0.0003
2023-11-14 2023-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 36,719 -44,298 -54.68 317 -62.29 0.0001
2023-08-14 2023-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 81,017 15,441 23.55 839 17.86 0.0002
2023-05-15 2023-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 65,576 -18,770 -22.25 712 -24.84 0.0002
2023-02-14 2022-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 84,346 -166,101 -66.32 946 -62.74 0.0002
2022-11-14 2022-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 250,447 234,539 1,474.35 2,539 1,663.19 0.0006
2022-08-15 2022-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 15,908 -635 -3.84 144 -8.86 0.0000
2022-05-16 2022-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 16,543 5,897 55.39 158 35.04 0.0000
2022-02-14 2021-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 10,646 10,646 117 0.0000
2021-02-16 2020-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 0 -148,752 -100.00 0 -100.00
2020-11-16 2020-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 148,752 -22,229 -13.00 2,199 -38.73 0.0006
2020-08-14 2020-06-30 13F THERAVANCE BIOPHARMA Cmn G8807B106 170,981 150,527 735.93 3,589 658.77 0.0013
2020-05-15 2020-03-31 13F THERAVANCE BIOPHARMA Cmn G8807B106 20,454 -948 -4.43 473 -14.62 0.0002
2020-02-14 2019-12-31 13F THERAVANCE BIOPHARMA Cmn G8807B106 21,402 3,999 22.98 554 95.07 0.0002
2019-08-14 2019-06-30 13F THERAVANCE BIOPHARMA Cmn G8807B106 17,403 -67,338 -79.46 284 -85.22 0.0001
2019-05-15 2019-03-31 13F THERAVANCE BIOPHARMA Cmn G8807B106 84,741 54,460 179.85 1,921 147.87 0.0010
2019-02-14 2018-12-31 13F THERAVANCE BIOPHARMA Cmn G8807B106 30,281 9,214 43.74 775 12.65 0.0004
2018-11-13 2018-09-30 13F THERAVANCE BIOPHARMA Cmn G8807B106 21,067 -11,715 -35.74 688 -7.40 0.0003
2018-08-14 2018-06-30 13F/A-1 THERAVANCE BIOPHARMA Cmn G8807B106 32,782 -52,318 -61.48 743 -76.28 0.0004
2018-08-10 2018-06-30 13F THERAVANCE BIOPHARMA Cmn G8807B106 32,782 -52,318 743
2017-05-12 2017-03-31 13F THERAVANCE BIOPHARMA Cmn G8807B106 85,100 85,100 159.59 3,133 321.67 0.0029
2017-01-31 2016-03-31 13F/A-1 THERAVANCE BIOPHARMA Cmn G8807B106 0 -13,537 -100.00 0 -100.00
2017-01-31 2015-12-31 13F/A-1 THERAVANCE BIOPHARMA Cmn G8807B106 13,537 13,537 0.00 222 0.0002
2016-02-12 2015-12-31 13F THERAVANCE BIOPHARMA Cmn G8807B106 13,537 222
2015-08-14 2015-06-30 13F THERAVANCE BIOPHARMA Cmn G8807B106 0 -38,111 -100.00 0 -100.00
2015-05-15 2015-03-31 13F THERAVANCE BIOPHARMA Cmn G8807B106 38,111 -9,981 -20.75 662 -7.67 0.0007
2015-02-17 2014-12-31 13F THERAVANCE BIOPHARMA Cmn G8807B106 48,092 34,089 243.44 717 121.98 0.0009
2014-11-14 2014-09-30 13F THERAVANCE BIOPHARMA Cmn G8807B106 14,003 -25,696 -64.73 323 -74.49 0.0004
2014-08-14 2014-06-30 13F THERAVANCE BIOPHARMA Cmn G8807B106 39,699 39,699 1,266 0.0017
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F THERAVANCE BIOPHARMA COM Call 19,900 323 n/a n/a n/a
2025-08-14 2025-06-30 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F THERAVANCE BIOPHARMA COM Call 700 16.67 6 20.00 n/a n/a n/a
2025-02-14 2024-12-31 13F THERAVANCE BIOPHARMA COM Call 600 200.00 6 400.00 n/a n/a n/a
2024-11-14 2024-09-30 13F THERAVANCE BIOPHARMA COM Call 200 -98.56 2 -99.15 n/a n/a n/a
2024-08-14 2024-06-30 13F THERAVANCE BIOPHARMA COM Call 13,900 892.86 118 875.00 n/a n/a n/a
2024-05-15 2024-03-31 13F THERAVANCE BIOPHARMA COM Call 1,400 -68.89 13 -76.00 n/a n/a n/a
2024-02-14 2023-12-31 13F THERAVANCE BIOPHARMA COM Call 4,500 -35.71 51 -16.67 n/a n/a n/a
2023-11-14 2023-09-30 13F THERAVANCE BIOPHARMA COM Call 7,000 -35.19 60 -45.95 n/a n/a n/a
2023-08-14 2023-06-30 13F THERAVANCE BIOPHARMA COM Call 10,800 27.06 112 20.65 n/a n/a n/a
2023-05-15 2023-03-31 13F THERAVANCE BIOPHARMA COM Call 8,500 -82.51 92 -83.12 n/a n/a n/a
2023-02-14 2022-12-31 13F THERAVANCE BIOPHARMA COM Call 48,600 170.00 545 197.81 n/a n/a n/a
2022-11-14 2022-09-30 13F THERAVANCE BIOPHARMA COM Call 18,000 80.00 183 101.10 n/a n/a n/a
2022-08-15 2022-06-30 13F THERAVANCE BIOPHARMA COM Call 10,000 -54.95 91 -57.08 n/a n/a n/a
2022-05-16 2022-03-31 13F THERAVANCE BIOPHARMA COM Call 22,200 -29.75 212 -39.26 n/a n/a n/a
2022-02-14 2021-12-31 13F THERAVANCE BIOPHARMA COM Call 31,600 -90.09 349 -85.21 n/a n/a n/a
2021-11-15 2021-09-30 13F THERAVANCE BIOPHARMA Cmn Call 318,800 2,359 n/a n/a n/a
2021-08-16 2021-06-30 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-21 2021-03-31 13F/A THERAVANCE BIOPHARMA COM Call 10,800 220 n/a n/a n/a
2021-05-17 2021-03-31 13F THERAVANCE BIOPHARMA COM Call 10,800 220 n/a n/a n/a
2020-05-15 2020-03-31 13F THERAVANCE BIOPHARMA Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F THERAVANCE BIOPHARMA Cmn Call 8,200 -57.51 212 -32.70 n/a n/a n/a
2019-08-14 2019-06-30 13F THERAVANCE BIOPHARMA Cmn Call 19,300 135.37 315 48.58 n/a n/a n/a
2019-02-14 2018-12-31 13F THERAVANCE BIOPHARMA Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F THERAVANCE BIOPHARMA Cmn Call 6,800 222 n/a n/a n/a
2016-05-13 2016-03-31 13F THERAVANCE BIOPHARMA Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A THERAVANCE BIOPHARMA Cmn Call 4,900 80 n/a n/a n/a
2016-02-12 2015-12-31 13F THERAVANCE BIOPHARMA Cmn Call 4,900 80 n/a n/a n/a
2015-11-16 2015-09-30 13F THERAVANCE BIOPHARMA Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F THERAVANCE BIOPHARMA Cmn Call 5,700 21.28 74 -9.76 n/a n/a n/a
2015-05-15 2015-03-31 13F THERAVANCE BIOPHARMA Cmn Call 4,700 176.47 82 228.00 n/a n/a n/a
2015-02-17 2014-12-31 13F THERAVANCE BIOPHARMA Cmn Call 1,700 -39.29 25 -61.54 n/a n/a n/a
2014-11-14 2014-09-30 13F THERAVANCE BIOPHARMA Cmn Call 2,800 21.74 65 -10.96 n/a n/a n/a
2014-08-14 2014-06-30 13F THERAVANCE BIOPHARMA Cmn Call 2,300 73 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F THERAVANCE BIOPHARMA COM Put 12,200 198 n/a n/a n/a
2025-08-14 2025-06-30 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F THERAVANCE BIOPHARMA COM Put 1,400 366.67 13 500.00 n/a n/a n/a
2025-02-14 2024-12-31 13F THERAVANCE BIOPHARMA COM Put 300 -75.00 3 -77.78 n/a n/a n/a
2024-11-14 2024-09-30 13F THERAVANCE BIOPHARMA COM Put 1,200 -61.29 10 -65.38 n/a n/a n/a
2024-08-14 2024-06-30 13F THERAVANCE BIOPHARMA COM Put 3,100 34.78 26 30.00 n/a n/a n/a
2024-05-15 2024-03-31 13F THERAVANCE BIOPHARMA COM Put 2,300 2,200.00 21 1,900.00 n/a n/a n/a
2024-02-14 2023-12-31 13F THERAVANCE BIOPHARMA COM Put 100 1 n/a n/a n/a
2023-11-14 2023-09-30 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F THERAVANCE BIOPHARMA COM Put 5,000 -83.05 52 -84.06 n/a n/a n/a
2023-05-15 2023-03-31 13F THERAVANCE BIOPHARMA COM Put 29,500 -11.14 320 -13.98 n/a n/a n/a
2023-02-14 2022-12-31 13F THERAVANCE BIOPHARMA COM Put 33,200 373 n/a n/a n/a
2022-02-14 2021-12-31 13F THERAVANCE BIOPHARMA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F THERAVANCE BIOPHARMA Cmn Put 21,400 158 n/a n/a n/a
2019-11-14 2019-09-30 13F THERAVANCE BIOPHARMA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F THERAVANCE BIOPHARMA Cmn Put 12,000 196 n/a n/a n/a
2016-05-13 2016-03-31 13F THERAVANCE BIOPHARMA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A THERAVANCE BIOPHARMA Cmn Put 100 2 n/a n/a n/a
2016-02-12 2015-12-31 13F THERAVANCE BIOPHARMA Cmn Put 100 2 n/a n/a n/a
2015-11-16 2015-09-30 13F THERAVANCE BIOPHARMA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F THERAVANCE BIOPHARMA Cmn Put 6,700 318.75 87 210.71 n/a n/a n/a
2015-05-15 2015-03-31 13F THERAVANCE BIOPHARMA Cmn Put 1,600 -52.94 28 -45.10 n/a n/a n/a
2015-02-17 2014-12-31 13F THERAVANCE BIOPHARMA Cmn Put 3,400 -65.66 51 -77.63 n/a n/a n/a
2014-11-14 2014-09-30 13F THERAVANCE BIOPHARMA Cmn Put 9,900 230.00 228 137.50 n/a n/a n/a
2014-08-14 2014-06-30 13F THERAVANCE BIOPHARMA Cmn Put 3,000 96 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.